Results 31 to 40 of about 126,231 (300)
Background: In view of the high incidence of infantile hemangioma (IH) in infants and young children, a comprehensive and reasonable evaluation scale for referral is urgently needed. This study compared the influence of the Hemangioma Severity Scale (HSS)
Tong Qiu+4 more
doaj +1 more source
The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis. [PDF]
To date the efficacy and safety of topical timolol in the treatment of infantile hemangioma has not been reviewed and analysed systematically. We collated all published data on the efficacy and safety of topical timolol in the treatment of infantile ...
Boyce, Aaron+5 more
core +3 more sources
Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma
Background Infantile hemangioma (IH) is characterized by proliferation and regression. Methods Based on the GSE127487 dataset, the differentially expressed genes (DEGs) between 6, 12, or 24 months and normal samples were screened, respectively.
Miao Xu+3 more
semanticscholar +1 more source
Biology of Infantile Hemangioma [PDF]
Infantile hemangioma (IH), the most common tumor of infancy, is characterized by an initial proliferation during infancy followed by spontaneous involution over the next 5-10 years, often leaving a fibro-fatty residuum. IH is traditionally considered a tumor of the microvasculature.
Tinte eItinteang+4 more
openaire +4 more sources
Background. Infantile hemangiomas are revealed in 1-3% of newborns and 10-12% of infants. There are only anecdotal reports on the laser therapy efficacy in this pathology management.
Tatyana S. Belysheva+6 more
doaj +1 more source
Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report [PDF]
[No abstract ...
Clerico, Anna+6 more
core +1 more source
Infantile hemangioma presenting as colocolic intussusception in an infant case report with review of pathologic lead points [PDF]
Infantile hemangioma (IH) is one of the most common vascular anomalies of early childhood and is usually recognized in the first few weeks to months of life as a solitary cutaneous lesion.
Dehner, Louis P.+3 more
core +2 more sources
Efficacy of Intravenous Propranolol for Life-threatening Diffuse Neonatal Hemangiomatosis [PDF]
Oral propranolol is recommended as the first-line agent for infantile hemangioma requiring systemic treatment. Life-threatening complications such as obstructive infantile hemangioma of the airway or infantile hepatic hemangioma associated with high ...
Ishikawa, Takamichi+2 more
core +1 more source
Importance Ulceration is a common complication of infantile hemangioma (IH), which leads to substantial morbidity. Ulceration in IH has not been systematically studied since the advent of β-blocker therapy for IH.
Esteban Fernández Faith+16 more
semanticscholar +1 more source
Propranolol for Infantile Hemangiomas
Abstract: Propranolol has been used successfully in a limited number of children with infantile hemangiomas. This multicenter retrospective study describes the efficacy and adverse effects of propranolol in infantile hemangioma. Seventy‐one infants with infantile hemangiomas were treated with oral propranolol, 1 mg/kg/12 hours, for at least 12 weeks ...
Antonio Baño+11 more
openaire +5 more sources